Activation of transforming growth factor-β/smad signaling reduces aggregate formation of mislocalized TAR DNA-binding protein-43

Neurodegenerative Diseases

Volumn 11, Issue 4, 2013, Pages 182-193

  Nakamura, Masataka ^a   Kaneko, Satoshi ^a   Ito, Hidefumi ^b   Jiang, Shiwen ^a   Fujita, Kengo ^a   Wate, Reika ^a   Nakano, Satoshi ^a   Fujisawa, Jun Ichi ^a   Kusaka, Hirofumi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aggregation; Amyotrophic lateral sclerosis; Smad; TAR DNA binding protein 43; Transforming growth factor

Indexed keywords

PROTEIN P62; SMAD2 PROTEIN; TAR DNA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; PROTEIN AGGREGATE; UBIQUITINATED PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL INCLUSION; CELL NUCLEUS; CYTOPLASM; DISEASE COURSE; DNA FRAGMENTATION; DOSE RESPONSE; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; AUTOPHAGOSOME; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DELETION MUTANT; ELECTROPHORETIC MOBILITY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INCUBATION TIME; MOLECULAR WEIGHT; PROTEIN DEGRADATION; SOLUBILITY;

AMYOTROPHIC LATERAL SCLEROSIS; CELL LINE; DNA-BINDING PROTEINS; HUMANS; NUCLEAR LOCALIZATION SIGNALS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84876416652     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000338151     Document Type: Article

References (27)

1. Iwata A, Riley BE, Johnston JA, Kopito RR: HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 2005; 280: 40282-40292.
2. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL, DiProspero NA, Knight MA, Schuldiner O, Padmanabhan R, Hild M, Berry DL, Garza D, Hubbert CC, Yao TP, Baehrecke EH, Taylor JP: HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447: 859-863.
3. Janen SB, Chaachouay H, Richter-Landsberg C: Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes. Glia 2010; 58: 1766-1774.
4. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W: Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 2008; 32: 16-25.
5. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
6. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
7. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM: Disturbance of nuclear and cytoplasmic tar DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 2008; 283: 13302-13309.
8. Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H: Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008; 64: 60-70.
9. Winton MJ, Van Deerlin VM, Kwong LK, Yuan W, Wood EM, Yu CE, Schellenberg GD, Rademakers R, Caselli R, Karydas A, Trojanowski JQ, Miller BL, Lee VM: A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett 2008; 582: 2252-2256.
10. Nonaka T, Arai T, Buratti E, Baralle FE, Akiyama H, Hasegawa M: Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 2009; 583: 394-400.
11. Mackenzie IR, Rademakers R, Neumann M: TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010; 9: 995-1007.
12. Hill CS: Nucleocytoplasmic shuttling of Smad proteins. Cell Res 2009; 19: 36-46.
13. Chalmers KA, Love S: Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. J Neuropathol Exp Neurol 2007; 66: 1019-1026.
14. Nakamura M, Ito H, Wate R, Nakano S, Hirano A, Kusaka H: Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model. Acta Neuropathol 2008; 115: 327-334.
15. Sawano A, Miyawaki A: Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semirandom mutagenesis. Nucleic Acids Res 2000; 28:E78.
16. Gassmann M, Grenacher B, Rohde B, Vogel J: Quantifying Western blots: pitfalls of densitometry. Electrophoresis 2009; 30: 1845-1855.
17. Kirkin V, McEwan DG, Novak I, Dikic I: A role for ubiquitin in selective autophagy. Mol Cell 2009; 34: 259-269.
18. Tanida I, Ueno T, Kominami E: LC3 and autophagy. Methods Mol Biol 2008; 445: 77-88.
19. Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, Gass J, Rangachari V, Buratti E, Baralle F, Golde TE, Dickson DW, Petrucelli L: Aberrant cleavage of TDP-enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 2009; 106: 7607-7612.
20. Urushitani M, Sato T, Bamba H, Hisa Y, Tooyama I: Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res 2010; 88: 784-797.
21. Schmierer B, Hill CS: TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970-982.
22. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, Vivien D: Transforming growth factor-beta and ischemic brain injury. Cell Mol Neurobiol 2003; 23: 539-550.
23. Okuyama N, Kiryu-Seo S, Kiyama H: Altered expression of Smad family members in injured motor neurons of rat. Brain Res 2007; 1132: 36-41.
24. Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G: Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J Neurosci 2010; 30: 5702-5712.
25. Gajewska M, Gajkowska B, Motyl T: Apoptosis and autophagy induced by TGF-B1 in bovine mammary epithelial BME-UV1 cells. J Physiol Pharmacol 2005; 56(suppl 3):143-157.
26. Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR, Sugimoto K, Miyazono K: Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 2009; 69: 8844-8852.
27. Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee SJ, Choi ME: TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem 2010; 285: 37909-37919.